Risk factors for extended-spectrum β-lactamase-producing Escherichia coli urinary tract infection in the community in Denmark: a case–control study M.

Slides:

Advertisements

Similar presentations

Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages

Advertisements

K. Kümmerer, A. Henninger Clinical Microbiology and Infection

Bloodstream infections among carriers of carbapenem-resistant Klebsiella pneumoniae: etiology, incidence and predictors S. Amit, H. Mishali, T. Kotlovsky,

Women with symptoms of a urinary tract infection but a negative urine culture: PCR- based quantification of Escherichia coli suggests infection in most.

R. Cantón, A. Novais, A. Valverde, E. Machado, L. Peixe, F. Baquero, T

I.J. Schalk Clinical Microbiology and Infection

Herpes zoster in non-hospitalized children

Migrant health—a cause for concern?

Evolution of extended-spectrum β-lactamases by mutation

K. Kümmerer, A. Henninger Clinical Microbiology and Infection

Extended-spectrum and CMY-type b-lactamase-producing Escherichia coli in clinical samples and retail meat from Pittsburgh, USA and Seville, Spain Y.

Current management of patients hospitalized with complicated skin and soft tissue infections across Europe (2010–2011): assessment of clinical practice.

Clinical characteristics of Haemophilus influenzae meningitis in Denmark in the post- vaccination era T.I. Pedersen, M. Howitz, C. Østergaard Clinical.

Host factors are more important in predicting recurrent Clostridium difficile infection than ribotype and use of antibiotics Y.H. van Beurden, S. Nezami,

Treatment of complicated skin and skin structure infections in areas with low incidence of antibiotic resistance—a retrospective population based study.

A.E. Muller, U. Theuretzbacher, J.W. Mouton

Extended-spectrum β-lactamase/AmpC- and carbapenemase-producing Enterobacteriaceae in animals: a threat for humans? J.-Y. Madec, M. Haenni, P. Nordmann,

How to evaluate and predict the ecologic impact of antibiotics: the pharmaceutical industry view from research and development R. Bax Clinical Microbiology.

Increased incidence of nitroimidazole-refractory giardiasis at the Hospital for Tropical Diseases, London: 2008–2013 L.E.B. Nabarro, R.A. Lever, M. Armstrong,

Women with symptoms of a urinary tract infection but a negative urine culture: PCR- based quantification of Escherichia coli suggests infection in most.

Is the prevalence of antibiotic-resistant organisms changing in Canadian hospitals? Comparison of point-prevalence survey results in 2010 and 2012 V.

Should standardized susceptibility testing for microbial biofilms be introduced in clinical practice? T. Coenye, D. Goeres, F. Van Bambeke, T. Bjarnsholt

Trends in length of stay, mortality and readmission among patients with community- acquired bacteraemia M. Søgaard, R.W. Thomsen, R.B. Bang, H.C. Schønheyder,

How to evaluate and predict the epidemiologic impact of antibiotic use in humans: the pharmacoepidemiologic approach D. Guillemot Clinical Microbiology.

Trends in antibiotic prescribing in general internal medicine wards: antibiotic use and indication for prescription B. Maraha, M. Bonten, H. Fiolet,

Travel to Asia and traveller's diarrhoea with antibiotic treatment are independent risk factors for acquiring ciprofloxacin-resistant and extended spectrum.

A multicentre analysis of epidemiology of the nosocomial bloodstream infections in Japanese university hospitals M. Nagao Clinical Microbiology and.

Vector control: a cornerstone in the malaria elimination campaign

Pharmacodynamics of doxycycline

G. Sakoulas Clinical Microbiology and Infection

J.P. Donnelly, B.E. De Pauw Clinical Microbiology and Infection

Switch to oral antibiotics in the treatment of infective endocarditis is not associated with increased risk of mortality in non–severely ill patients

New Delhi metallo-beta-lactamase (NDM-1): towards a new pandemia?

Public health impact of isoniazid-resistant Mycobacterium tuberculosis strains with a mutation at amino-acid position 315 of katG: a decade of experience.

B. Gordts Clinical Microbiology and Infection

Control of infections due to extended-spectrum β-lactamase-producing organisms in hospitals and the community R.E. Warren, G. Harvey, R. Carr, D. Ward,

Regional distribution of nosocomial infections due to ESBL-positive Enterobacteriaceae in Germany: data from the German National Reference Center for.

Four-year epidemiological study of extended-spectrum β-lactamase-producing Enterobacteriaceae in a French teaching hospital L. Gibold, F. Robin, R.-N.

Levofloxacin in the treatment of ventilator-associated pneumonia

R. Bitterman, M. Paul, D. Polak, Y. Geffen

J. Bodilsen, C. T. Brandt, A. Sharew, M. Dalager-Pedersen, T

Metagenomics and probiotics

M. Aires-de-Sousa Clinical Microbiology and Infection

Previously unknown species of Aspergillus

Systematic review of antibiotic consumption in acute care hospitals

Long-term study of the frequency of Escherichia coli and Klebsiella pneumoniae isolates producing extended-spectrum β-lactamases L. Romero, L. López,

Pandemic lineages of extraintestinal pathogenic Escherichia coli

Testing patients with non-specific symptoms for antibodies against Borrelia burgdorferi sensu lato does not provide useful clinical information about.

Vaccinations against respiratory tract infections at Hajj

C. Gagliotti, L. Nobilio, M.L. Moro

Prevalence and diversity of extended-spectrum ß-lactamases in faecal Escherichia coli isolates from healthy humans in Spain L. Vinué, Y. Sáenz, S. Martínez,

Increasing numbers of hospitalizations and deaths with mention of Clostridium difficile infection, north-eastern Italy, 2008–2013 U. Fedeli, E. Schievano,

R. Cantón, A. Novais, A. Valverde, E. Machado, L. Peixe, F. Baquero, T

Clinical Microbiology and Infection

I. Bitar, A. Piazza Clinical Microbiology and Infection

Antibiotic resistance patterns of more than clinical Escherichia coli isolates in Southeast Austria, 1998–2013 A. Badura, G. Feierl, G. Pregartner,

Active surveillance of antibiotic resistance prevalence in urinary tract and skin infections in the outpatient setting A. Kronenberg, S. Koenig, S. Droz,

K. Kaier, N.T. Mutters, U. Frank Clinical Microbiology and Infection

Results of two worldwide surveys into physician awareness and perceptions of extended-spectrum β-lactamases H. Goossens, S. Malhotra-Kumar, H. Eraksoy,

The atypical pneumonias: clinical diagnosis and importance

Predominance of SHV-5 β-lactamase in enteric bacteria causing community-acquired urinary tract infections in Bosnia and Herzegovina S. Uzunovic-Kamberovic,

Virology: a scientific discipline facing new challenges

New oral cephalosporins in pediatric community-acquired infections

Incidence, clinical characteristics and 30-day mortality of enterococcal bacteraemia in Denmark 2006–2009: a population-based cohort study M. Pinholt,

J.L. Balcázar Clinical Microbiology and Infection

G.C. Schito Clinical Microbiology and Infection

Impact of antibiotic restrictions: the patient's perspective

Comparative study of pediculicidal effect of medical plants

CMI readers' survey Clinical Microbiology and Infection

The future of diagnostic bacteriology

Presentation transcript:

Risk factors for extended-spectrum β-lactamase-producing Escherichia coli urinary tract infection in the community in Denmark: a case–control study M. Søgaard, U. Heide-Jørgensen, J.P. Vandenbroucke, H.C. Schønheyder, C.M.J.E. Vandenbroucke-Grauls Clinical Microbiology and Infection Volume 23, Issue 12, Pages 952-960 (December 2017) DOI: 10.1016/j.cmi.2017.03.026 Copyright © 2017 European Society of Clinical Microbiology and Infectious Diseases Terms and Conditions

Fig. 1 Risk of extended spectrum β-lactamase (ESBL) associated with previous exposure to systemic antibiotics compared with (a) controls with non-ESBL Escherichia coli urinary tract infection, and (b) general population controls. Antibiotic exposure include all reimbursed antibiotics dispensed from pharmacies in the region, whereas in-hospital antibiotic exposure is not included. Clinical Microbiology and Infection 2017 23, 952-960DOI: (10.1016/j.cmi.2017.03.026) Copyright © 2017 European Society of Clinical Microbiology and Infectious Diseases Terms and Conditions

Fig. 2 Risk of extended spectrum β-lactamase (ESBL) associated with previous hospitalization compared with controls with non-ESBL Escherichia coli urinary tract infection. Clinical Microbiology and Infection 2017 23, 952-960DOI: (10.1016/j.cmi.2017.03.026) Copyright © 2017 European Society of Clinical Microbiology and Infectious Diseases Terms and Conditions

Fig. 3 Risk of extended spectrum β-lactamase (ESBL) associated with surgical procedures except skin and soft tissue compared with controls with non-ESBL Escherichia coli urinary tract infection. Clinical Microbiology and Infection 2017 23, 952-960DOI: (10.1016/j.cmi.2017.03.026) Copyright © 2017 European Society of Clinical Microbiology and Infectious Diseases Terms and Conditions